{"id":967018,"date":"2026-05-26T16:12:07","date_gmt":"2026-05-26T20:12:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\/"},"modified":"2026-05-26T16:12:07","modified_gmt":"2026-05-26T20:12:07","slug":"molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\/","title":{"rendered":"Molecular Partners to Present at TD Cowen\u2019s 7th Annual Oncology Innovation Summit"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May  26, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WW5jUn9j0WM359pZQNxsRGEjeiU6xfppXhW3ckmILgah9QG2AbuiqdlXr99dBmRfN0ixWwBi5p_AtxUJqLSad2i0BT9GKPFOII9j_-RqGxc=\" rel=\"nofollow\" target=\"_blank\">Molecular Partners<\/a>\u00a0AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (\u201cMolecular Partners\u201d or the \u201cCompany\u201d), today announced that members of the management team will participate in the following upcoming investor conference.<\/p>\n<p>\n        <strong>TD Cowen\u2019s 7th\u00a0Annual Oncology Innovation Summit: Insights for ASCO &amp; EHA:<\/strong>\n      <\/p>\n<ul>\n<li>Fireside chat on Wednesday, May 27, 2026 beginning at 11:30am ET\n<\/li>\n<\/ul>\n<p>The event will be webcast and available on the Molecular Partners\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zciPBHQ3HTVX2V-8iEvgdrK_jSl4iUdLsN3YDCFdp-qU-yMC-aScbLLQJqOa-54OcOayV_wWoqDMec5sLln8vBdiTXTZ5tYbn8krDQ9Ixnk=\" rel=\"nofollow\" target=\"_blank\">website,<\/a> under the investors tab.<\/p>\n<p>\n        <strong>About Molecular Partners AG<\/strong>\u00a0<br \/>Molecular Partners AG (SIX: MOLN, NASDAQ: MOLN) is a clinical-stage biotech company pioneering a novel class of protein drugs known as DARPin therapeutics, for medical challenges other treatment modalities cannot readily address. Molecular Partners leverages the key properties of DARPins to design and develop differentiated therapeutics for cancer patients, including targeted radiopharmaceuticals and next-generation immune cell engagers. The Company has proprietary programs in various stages of pre-clinical and clinical development, as well as programs developed through partnerships with leading pharmaceutical companies and academic centers. Molecular Partners, founded in 2004, has offices in both Zurich, Switzerland and Concord, MA, USA. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=N0KJG0-wJ_O8uMkiMQKkjMaXiab-Qd8-W21yGXDK_XdKMsmIvag132q--S7MQCVdGMu-H8EGWPmtQgU7fzKuz0V4CfQEn9hV4wnKTURIG8xK0FYCysLgqaRjsIEueN3GH6zn7bVkpieEaf-pIfK1GdTSEe3jb2EqWDlnA5kvqGWocvMU7v9XZIev37h7YCdfJsVfkJl6aGA_YsgeTtIaE7zdebQDWZoymtivmbz5nYGopI6AK6p2RnqewIvPaucEeL2fraQhJ9CSkIyWtv9rdXMTvUXGC8bApEAqCxKgLZQ=\" rel=\"nofollow\" target=\"_blank\">www.molecularpartners.com<\/a> and find us on LinkedIn and Twitter \/ X @MolecularPrtnrs.<\/p>\n<p>\n        <strong>For further details, please contact:<\/strong><br \/>\n        <br \/>Seth Lewis, EVP Corporate Finance<br \/>Concord, Massachusetts, U.S.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mwKdTozNa_LrzIfT7YRGub3xr4s7Y-0Nr4MnvNGaZj9nJuwLlYr-oyUVTtplsSRdgFYofFcfw_TSFGUp0FD-OSAO9_fcE2iUAxr6OlA-7O9dsLNoU6Innq8kCudv94YycIoq4P5Od_kF6Aj4uy1BOA==\" rel=\"nofollow\" target=\"_blank\">seth.lewis@molecularpartners.com<\/a><br \/>Tel: +1 781 420 2361<\/p>\n<p>Laura Jeanbart, PhD, Head of Portfolio Management &amp; Communications<br \/>Zurich-Schlieren, Switzerland<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dyVr3fSPvX4RSuQDOXEDGsFEYHDbJYF2bzQJu3lClghRfkRarGABphRc2azQ35tFKwgzBu9jujZWLzPh4WDFzEDgSqhSZEaGcG6Q9jzmxG6Ke8kSq1rA5I_nZTYYrzPEywshekGySEMuyUM94sRHQw==\" rel=\"nofollow\" target=\"_blank\">laura.jeanbart@molecularpartners.com<\/a><br \/>Tel: +41 44 575 19 35<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjczOSM3NjIxODUyIzIyMDQ5OTU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YjhiZTM3YzYtZjFiNS00MjExLWFmNjYtNDFiZGM5NmIzNjMyLTEyMTY1NDgtMjAyNi0wNS0yNi1lbg==\/tiny\/Molecular-Partners.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 26, 2026 (GLOBE NEWSWIRE) &#8212; Molecular Partners\u00a0AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (\u201cMolecular Partners\u201d or the \u201cCompany\u201d), today announced that members of the management team will participate in the following upcoming investor conference. TD Cowen\u2019s 7th\u00a0Annual Oncology Innovation Summit: Insights for ASCO &amp; EHA: Fireside chat on Wednesday, May 27, 2026 beginning at 11:30am ET The event will be webcast and available on the Molecular Partners\u00a0website, under the investors tab. About Molecular Partners AG\u00a0Molecular Partners AG (SIX: MOLN, NASDAQ: MOLN) is a clinical-stage biotech company pioneering a novel class of protein drugs known as DARPin therapeutics, for medical challenges &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Molecular Partners to Present at TD Cowen\u2019s 7th Annual Oncology Innovation Summit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-967018","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Molecular Partners to Present at TD Cowen\u2019s 7th Annual Oncology Innovation Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Molecular Partners to Present at TD Cowen\u2019s 7th Annual Oncology Innovation Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 26, 2026 (GLOBE NEWSWIRE) &#8212; Molecular Partners\u00a0AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (\u201cMolecular Partners\u201d or the \u201cCompany\u201d), today announced that members of the management team will participate in the following upcoming investor conference. TD Cowen\u2019s 7th\u00a0Annual Oncology Innovation Summit: Insights for ASCO &amp; EHA: Fireside chat on Wednesday, May 27, 2026 beginning at 11:30am ET The event will be webcast and available on the Molecular Partners\u00a0website, under the investors tab. About Molecular Partners AG\u00a0Molecular Partners AG (SIX: MOLN, NASDAQ: MOLN) is a clinical-stage biotech company pioneering a novel class of protein drugs known as DARPin therapeutics, for medical challenges &hellip; Continue reading &quot;Molecular Partners to Present at TD Cowen\u2019s 7th Annual Oncology Innovation Summit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-26T20:12:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjczOSM3NjIxODUyIzIyMDQ5OTU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Molecular Partners to Present at TD Cowen\u2019s 7th Annual Oncology Innovation Summit\",\"datePublished\":\"2026-05-26T20:12:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\\\/\"},\"wordCount\":255,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNjczOSM3NjIxODUyIzIyMDQ5OTU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\\\/\",\"name\":\"Molecular Partners to Present at TD Cowen\u2019s 7th Annual Oncology Innovation Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNjczOSM3NjIxODUyIzIyMDQ5OTU=\",\"datePublished\":\"2026-05-26T20:12:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNjczOSM3NjIxODUyIzIyMDQ5OTU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNjczOSM3NjIxODUyIzIyMDQ5OTU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Molecular Partners to Present at TD Cowen\u2019s 7th Annual Oncology Innovation Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Molecular Partners to Present at TD Cowen\u2019s 7th Annual Oncology Innovation Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\/","og_locale":"en_US","og_type":"article","og_title":"Molecular Partners to Present at TD Cowen\u2019s 7th Annual Oncology Innovation Summit - Market Newsdesk","og_description":"ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 26, 2026 (GLOBE NEWSWIRE) &#8212; Molecular Partners\u00a0AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (\u201cMolecular Partners\u201d or the \u201cCompany\u201d), today announced that members of the management team will participate in the following upcoming investor conference. TD Cowen\u2019s 7th\u00a0Annual Oncology Innovation Summit: Insights for ASCO &amp; EHA: Fireside chat on Wednesday, May 27, 2026 beginning at 11:30am ET The event will be webcast and available on the Molecular Partners\u00a0website, under the investors tab. About Molecular Partners AG\u00a0Molecular Partners AG (SIX: MOLN, NASDAQ: MOLN) is a clinical-stage biotech company pioneering a novel class of protein drugs known as DARPin therapeutics, for medical challenges &hellip; Continue reading \"Molecular Partners to Present at TD Cowen\u2019s 7th Annual Oncology Innovation Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-26T20:12:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjczOSM3NjIxODUyIzIyMDQ5OTU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Molecular Partners to Present at TD Cowen\u2019s 7th Annual Oncology Innovation Summit","datePublished":"2026-05-26T20:12:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\/"},"wordCount":255,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjczOSM3NjIxODUyIzIyMDQ5OTU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\/","name":"Molecular Partners to Present at TD Cowen\u2019s 7th Annual Oncology Innovation Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjczOSM3NjIxODUyIzIyMDQ5OTU=","datePublished":"2026-05-26T20:12:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjczOSM3NjIxODUyIzIyMDQ5OTU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjczOSM3NjIxODUyIzIyMDQ5OTU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-partners-to-present-at-td-cowens-7th-annual-oncology-innovation-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Molecular Partners to Present at TD Cowen\u2019s 7th Annual Oncology Innovation Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/967018","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=967018"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/967018\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=967018"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=967018"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=967018"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}